Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
NYS Entity Status
NYS Filing Date
JUNE 20, 2014
NYS DOS ID#
973 PLYMOUTH ST
PELHAM MANOR, NEW YORK, 10803
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - GENE & JEANNE LLC
Around the Web
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
- Spooked by Real Life? Bring On the Halloween Frights
By ISAAC OLIVER - Thursday Oct 26, 2017
A writer put himself through four haunted houses and theater experiences to see if he could hack it. Here is his (haunted) story.
- Vote for WSJ's House of the Week
Friday Jun 8, 2012
Stefanos Chen on Lunch Break shows us the latest homes vying to be WSJ's House of the Week, including a high-altitude house in Lake Tahoe, a Spanish-style home in Oklahoma, an English manor in Atlanta and a Bedford, N.Y. home built from the remnants of an old dairy barn. Photo: Steve Turner.
- How Exactly Does Gene Transfer via AAV Work?
Friday Jul 14, 2017
Adeno-associated virus (AAV) vectors are frequently utilized as viral vectors for gene therapy.
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.